Intrommune Develops Innovative Toothpaste Immunotherapy for Treating Peanut Allergy

Reading Time: < 1 minute

 

INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE.

 

Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed William Reisacher.

Recently Kevin Price visited with Dr. William Reisacher, MD and they discussed Intrommune.

While the world is focused on the Coronavirus pandemic, more than 32 million people worldwide are already battling the food allergy epidemic. And, while the only treatment for food allergy anaphylaxis until 2020 has been rescue therapy with an epipen, peanut immunotherapy is emerging as a treatment option for peanut allergy. More than 3 million people, including an estimated 1.7 million children, have peanut allergy in the U.S.

Intrommune Therapeutics (www.intrommune.com) is developing a patient-friendly immunotherapy treatment called INT-301 for peanut allergy. INT301 is in the Oral mucosal immunotherapy (OMIT) class of drugs and uses a specially formulated toothpaste to stabilize and deliver allergenic proteins to immunologically active areas of the oral cavity with the greatest potential for allergy desensitization.

Success with allergy immunotherapy hinges on consistent exposure of a patient’s immune system to gradually “desensitize” the patient to the specific allergy trigger over time. Using this toothpaste promises advantages over other approaches to allergy immunotherapy due to its targeted delivery, simplified administration, and support of reliable, long-term adherence. Other peanut allergy immunotherapies require ingestion of peanut protein powder or drops.

LISTEN TO THE INTERVIEW IN ITS ENTIRETY HERE:

The Price of Business is one of the longest running shows of its kind in the country and is in markets coast to coast. The Host, Kevin Price, is a multi-award winning author, broadcast journalist, and syndicated columnist. Learn more about the show and its digital partners at www.PriceofBusiness.com (scroll down to the bottom of the page).

Share This:

About kevin 1548 Articles
No articles on this site should be construed as the opinion of PriceofBusiness.com. Do your homework, get expert advice before following the advice on this or any other site.

Be the first to comment

Leave a Reply

Your email address will not be published.


*